Q2 Earnings Estimate for Vital Farms Issued By William Blair

Vital Farms, Inc. (NASDAQ:VITL) – William Blair issued their Q2 2025 earnings estimates for Vital Farms in a research note issued on Thursday, February 27th. William Blair analyst J. Andersen anticipates that the company will post earnings per share of $0.27 for the quarter. William Blair has a “Outperform” rating on the stock. The consensus estimate for Vital Farms’ current full-year earnings is $1.11 per share. William Blair also issued estimates for Vital Farms’ Q3 2025 earnings at $0.26 EPS, FY2025 earnings at $1.28 EPS and FY2026 earnings at $1.54 EPS.

Other equities research analysts also recently issued reports about the stock. Stifel Nicolaus upgraded shares of Vital Farms from a “hold” rating to a “buy” rating and set a $44.00 price target for the company in a research report on Friday, February 28th. Jefferies Financial Group reduced their price target on shares of Vital Farms from $45.00 to $41.00 and set a “buy” rating for the company in a research report on Monday, November 11th. TD Cowen lifted their price target on shares of Vital Farms from $41.00 to $45.00 and gave the company a “buy” rating in a research report on Wednesday, January 8th. Telsey Advisory Group restated an “outperform” rating and set a $52.00 price objective on shares of Vital Farms in a research report on Friday, February 28th. Finally, Craig Hallum started coverage on Vital Farms in a research report on Friday, December 20th. They set a “buy” rating and a $50.00 price objective for the company. Eight research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $44.57.

Vital Farms Price Performance

VITL stock opened at $31.15 on Monday. The firm has a 50 day moving average of $38.38 and a 200-day moving average of $35.73. Vital Farms has a 12-month low of $18.26 and a 12-month high of $48.41. The company has a current ratio of 3.24, a quick ratio of 2.81 and a debt-to-equity ratio of 0.04. The company has a market cap of $1.36 billion, a price-to-earnings ratio of 27.81 and a beta of 0.90.

Vital Farms (NASDAQ:VITL) last announced its quarterly earnings data on Thursday, February 27th. The company reported $0.23 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.08. The firm had revenue of $165.99 million during the quarter, compared to the consensus estimate of $160.32 million. Vital Farms had a net margin of 8.68% and a return on equity of 22.29%.

Insiders Place Their Bets

In other Vital Farms news, CEO Russell Diez-Canseco sold 44,728 shares of Vital Farms stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $37.66, for a total value of $1,684,456.48. Following the completion of the sale, the chief executive officer now directly owns 613,797 shares of the company’s stock, valued at approximately $23,115,595.02. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Matthew Ohayer sold 24,000 shares of Vital Farms stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $43.19, for a total transaction of $1,036,560.00. Following the completion of the sale, the insider now directly owns 7,014,890 shares of the company’s stock, valued at $302,973,099.10. The trade was a 0.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 190,202 shares of company stock valued at $7,855,957. Company insiders own 27.60% of the company’s stock.

Institutional Trading of Vital Farms

Several institutional investors have recently made changes to their positions in VITL. DekaBank Deutsche Girozentrale grew its stake in shares of Vital Farms by 27.0% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 8,301 shares of the company’s stock valued at $291,000 after buying an additional 1,763 shares during the period. Emerald Mutual Fund Advisers Trust grew its stake in shares of Vital Farms by 93.9% during the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 531,676 shares of the company’s stock valued at $18,646,000 after buying an additional 257,492 shares during the period. Harbor Capital Advisors Inc. purchased a new stake in shares of Vital Farms during the 3rd quarter valued at $1,798,000. Emerald Advisers LLC grew its stake in shares of Vital Farms by 106.8% during the 3rd quarter. Emerald Advisers LLC now owns 706,440 shares of the company’s stock valued at $24,775,000 after buying an additional 364,837 shares during the period. Finally, Robeco Institutional Asset Management B.V. grew its stake in shares of Vital Farms by 4.4% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 7,857 shares of the company’s stock valued at $276,000 after buying an additional 329 shares during the period. 98.59% of the stock is owned by hedge funds and other institutional investors.

Vital Farms Company Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.